SCROLL DOWN
Research and products
At CanSinoBIO, our main research and development focus is vaccines.
Areas Of Focus
We apply our expertise across a range targets from antigen discovery, antigen overexpression, purification and formulation to proof-of-concept pre-clinical evaluation, production process development and assay development.
Pipeline
We have an impressive array of vaccine candidates currently undergoing pre-clinical studies including recombinant protein-based pneumococcal vaccines, adenovirus-based recombinant TB vaccines, and polyvalent conjugate vaccines.
Technology Platform
Our team works with world’s most advanced equipment and lab resources for microbiology, molecular cell biology, immunology and biochemistry. We also maintain top- notch animal research facilities.
Areas of focus
Pipeline
Technology platforms
Investors
We apply our expertise across a range targets from antigen discovery, antigen overexpression,
purification and formulation to proof-of-concept pre-clinical evaluation,
production process development and assay development.
Information disclosure
Stock information
Corporate governance
Calendar
Top